Identification Of Protein That Produces 'Good' Fat, Has Potential To Treat, Prevent Obesity

Main Category: Obesity / Weight Loss / Fitness
Also Included In: Biology / Biochemistry;  Diabetes;  Genetics
Article Date: 22 Aug 2008 - 1:00 PDT

email to a friend   printer friendly   opinions  

A study by researchers at the Joslin Diabetes Center has shown that a protein known for its role in inducing bone growth can also help promote the development of brown fat, a "good" fat that helps in the expenditure of energy and plays a role in fighting obesity.

"Obesity is occurring at epidemic rates in the U.S. and worldwide and that impacts the risk and prognosis of many diseases," said Yu-Hua Tseng, Ph.D. an Assistant Investigator in the Joslin Section on Obesity and Hormone Action and lead author of the paper published in Nature. "We hope this study can be translated into applications to help treat or prevent obesity."

Tseng noted that obesity is a major risk factor for type 2 diabetes and is closely linked to the metabolic syndrome, a collection of medical problems associated with insulin resistance that can lead to an increased risk of atherosclerosis, the buildup of plaque in coronary arteries that leads to heart attack and stroke.

In laboratory studies of mouse cells, Tseng and her colleagues identified that a bone-inducing protein called BMP-7 drives precursor cells that give rise to mature brown fat cells. According to Tseng, there are two main types of fat cells in the body - white and brown.

"White fat cells are the 'conventional' form of fat designed to store energy. By contrast, the main role of brown fat is to burn calories by generating heat. Brown fat cells largely disappear by adulthood in humans, but their precursors still remain in the body," Tseng explained.

A 2005 Joslin study by Dr. Tseng and colleagues discovered genes that control the creation of the precursor cells of brown fat. Another more recent 2007 Joslin study led by C. Ronald Kahn, M.D., head of the Joslin Section on Obesity and Hormone Action and also a co-author of the current Nature study, found clusters of brown fat cells dispersed between bundles of muscle fibers in an obesity-resistant strain of mice.

Now, this latest study identified BMP-7 as the protein capable of inducing the formation and function of brown fat cells. According to the paper, delivery of BMP-7 into mice using adenovirus as a vector resulted in an increase in the development of brown fat tissue. In one of the experiments, the mice that developed brown fat tissue gained less weight than those that did not. In another experiment, mice that received injections of progenitor cells - similar to stem cells - that had been pre-treated with BMP-7 also developed additional brown fat tissue.

The study sought to address a fundamental question in adipocyte biology, namely what controls the development of fat depots. BMPs are a family of proteins known to regulate organ formation during embryonic development. In this study, Dr. Tseng and her colleagues proposed that different members of BMPs determine brown versus white fat cell fate. Scientists hope that improved knowledge of fat development will lead to new drugs or therapeutic approaches to fight obesity.

"Diet and exercise are still the best approaches for weight reduction in the general population," Tseng said. "However, for people who are genetically predisposed to obesity, these approaches may have very little effect."

"As we learn more about the controls of brown fat development, medical interventions to increase energy expenditure by brown fat inducing agents, such as BMP-7, may provide hope to these individuals in losing weight and preventing the metabolic disorders associated with obesity," she said.

###

The study was funded by grants from the National Institutes of Health, the Tanita Healthy Weight Community and the Miles Shore 50th Anniversary Scholar Program of Harvard Medical School.

Others participating in the research were Tim J. Schultz, Tian Lian Huang, Jonathon N. Winnay, Cullen M. Taniguchi, Thien T. Tran, Ryo Suzuki, Daniel O. Espinosa, Yuji Yakamoto and C. Ronald Kahn, the Mary K. Iacocca Professor of Medicine at Harvard Medical School, all of the Joslin Section on Obesity and Hormone Action; Efi Kokkotou of Beth Israel Deaconess Medical Center; Molly J. Ahrens and Andrew T. Dudley of Northwestern University; Andrew W. Norris of University of Iowa Children's Hospital; and Rohit N. Kulkarni of the Joslin Section on Cellular and Molecular Physiology.

About Joslin Diabetes Center

Joslin Diabetes Center is the world's preeminent diabetes clinic, diabetes research center and provider of diabetes education. Joslin is dedicated to ensuring people with diabetes live long, healthy lives and offers real hope and progress toward diabetes prevention and a cure for the disease. Founded in 1898 by Elliott P. Joslin, M.D., Joslin is an independent nonprofit institution affiliated with Harvard Medical School. For more information about Joslin, call 1-800-JOSLIN-1 or visit http://www.joslin.org/.

Source: Kira Jastive
Joslin Diabetes Center

• Additional
• References
• Citations